Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy.
about
Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transient potential receptor m ...... itro response to chemotherapy.
@en
Transient potential receptor melastatin-2
@nl
type
label
Transient potential receptor m ...... itro response to chemotherapy.
@en
Transient potential receptor melastatin-2
@nl
prefLabel
Transient potential receptor m ...... itro response to chemotherapy.
@en
Transient potential receptor melastatin-2
@nl
P2093
P2860
P1476
Transient potential receptor m ...... vitro response to chemotherapy
@en
P2093
Anne-Laure Perraud
Jessica N Haladyna
Simone S Riedel
Taylor Pastuer
P2860
P304
596-602.e3
P356
10.1016/J.EXPHEM.2016.03.006
P577
2016-03-24T00:00:00Z